<DOC>
	<DOC>NCT00106496</DOC>
	<brief_summary>The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term management of Atopic Dermatitis</brief_summary>
	<brief_title>A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis</brief_title>
	<detailed_description>Study includes an interim short-term, open label period. Patients could also receive a second course of open label treatment dependent on disease exacerbation.</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patient must have Atopic Dermatitis Patient must be at least 2 years of age Patient is pregnant or breast feeding an infant</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Immunomodulator, Topical</keyword>
	<keyword>Tacrolimus, Topical</keyword>
	<keyword>Dermatitis, Atopic</keyword>
	<keyword>Eczema, Atopic</keyword>
	<keyword>Atopic Dermatitis</keyword>
</DOC>